BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 3, 2006
View Archived Issues
Malaria vaccines safe in early investigations
Read More
Galantamine and smoking cessation / News in Context
Read More
Cyclacel completes Xcyte transactions
Read More
University of Washington to study effects of TH-9507 on cognitive function
Read More
Provigil granted six months of pediatric exclusivity
Read More
Launch activities continue for Yaz
Read More
TNFerade begins new phase II study in metastatic melanoma
Read More
First clinical trials demonstrate transdermal delivery of hPTH (1-34)
Read More
Reinitiation of Tysabri clinical trial dosing in multiple sclerosis
Read More
Relenza approved for prophylactic use, GSK advances pandemic flu vaccines
Read More
Eisai and DNAVEC collaborate on Alzheimer's disease vaccine
Read More
sBLA submission for first-line use of Rituxan in NHL
Read More
New phase II trial investigates erdosteine for COPD-associated chronic bronchitis
Read More
Fast track designation for PTC-124 in Duchenne muscular dystrophy
Read More
IND cleared for clinical studies of NIC5-15 for Alzheimer's disease
Read More
First clinical trial of gene therapy for muscular dystrophy now under way
Read More
Results of phase II study of surfactant lavage for ARDS
Read More
Lacosamide has clinically relevant effect in neuropathic pain
Read More
Maribavir significantly reduces CMV reactivation
Read More
New therapeutics for cancer covered in recent patent literature
Read More
Recent patents report new treatments for depression, anxiety, sleep disorders, etc.
Read More
Recent Array BioPharma patent discloses novel agents for immunoregulatory disorders
Read More
Prograf approved for use in heart transplant patients
Read More
NDA submitted for intravenous RSD-1235
Read More
Takeda submits NDA for ACTOplus met XR
Read More
In vivo antitumor efficacy of TL-310 reported, compound advanced into clinic
Read More
TPI-287 demonstrates good oral activity and greater potency than paclitaxel in preclinical studies
Read More
Novel series of VLA-1 integrin inhibitors developed by Icos
Read More
Spotlight on liver X receptor agonists as potential antiatherosclerotic drugs
Read More
Approvable letter for Xenazine in Huntington's disease-associated chorea
Read More